NovImmune, Roche in antibody deal

NovImmune S.A. (Geneva, Switzerland) granted Genentech Inc. exclusive rights to a preclinical anti-IL-17 human mAb, with access to backup antibodies. NovImmune will receive an upfront payment and is e...